Literature DB >> 18667489

Hepatosplenic T cell lymphoma in inflammatory bowel disease.

Matthew Shale1, Ed Kanfer, Remo Panaccione, Subrata Ghosh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18667489     DOI： 10.1136/gut.2008.163279

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  34 in total

Review 1.  Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Authors:  Kara Bradford; David Q Shih
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Ulcerative colitis: current treatment strategies and future prospects.

Authors:  Sagar Garud; Mark A Peppercorn
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

3.  Gastric ulcers and swollen kidneys: a rare diagnosis complicating Crohn's disease.

Authors:  C Ormerod; S Sarkar; B Woodcock; D White; S Lal
Journal:  BMJ Case Rep       Date:  2010-09-07

Review 4.  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors:  D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

Review 5.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

6.  Long-term outcome of laparoscopic ileocecal resection for Crohn's disease before the era of biologics.

Authors:  Andreas D Rink; Ivo R Fischer; Boris Vestweber; Karl-Heinz Vestweber
Journal:  Int J Colorectal Dis       Date:  2013-07-16       Impact factor: 2.571

Review 7.  Therapy for Crohn's Disease: a Review of Recent Developments.

Authors:  Gregory J Eustace; Gil Y Melmed
Journal:  Curr Gastroenterol Rep       Date:  2018-04-05

8.  Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.

Authors:  Stefano Scaringi; Carmela Di Martino; Daniela Zambonin; Marilena Fazi; Giuseppe Canonico; Francesca Leo; Ferdinando Ficari; Francesco Tonelli
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

Review 9.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

Review 10.  The current state of the art for biological therapies and new small molecules in inflammatory bowel disease.

Authors:  Sudarshan Paramsothy; Adam K Rosenstein; Saurabh Mehandru; Jean-Frederic Colombel
Journal:  Mucosal Immunol       Date:  2018-06-15       Impact factor: 7.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.